




Searching News Database: Kedrion
HSMN NewsFeed - 2 Oct 2024
Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo(R) in the US
Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo(R) in the US
HSMN NewsFeed - 1 Sep 2016
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
HSMN NewsFeed - 13 Mar 2007
Kedrion and ProMetic Form Strategic Alliance to Develop Orphan Drugs from Plasma
Kedrion and ProMetic Form Strategic Alliance to Develop Orphan Drugs from Plasma
HSMN NewsFeed - 16 Jan 2007
Nabi Biopharmaceuticals Announces Initiation of Civacir(R) Phase II 'Proof-of- Concept' Clinical Trial
Nabi Biopharmaceuticals Announces Initiation of Civacir(R) Phase II 'Proof-of- Concept' Clinical Trial
HSMN NewsFeed - 29 Jun 2006
Nabi Biopharmaceuticals Secures Agreement with Kedrion to Co-Develop and Commercialize Civacir(R) in Europe
Nabi Biopharmaceuticals Secures Agreement with Kedrion to Co-Develop and Commercialize Civacir(R) in Europe